Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Depression Schizophrenia Article Inspiring efforts to improve mental health across countries and ages Migraine Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine Mental Health Congress highlights Article Telehealth and the ‘digital clinic’ in psychiatry practice Anxiety Depression Article Anxiety and depression in fibromyalgia